Sick Economics

Searching For Healthy Profits In The Stock Market

Sick Economics. Healthcare Investing Tips & Analysis. Big Pharma, Biotech, Medical Devices, Healthcare REITs & More.

SICK PICKS


Our favorite biotech shares and healthcare investments in today’s stock market. Highlighting companies that stand to profit through medical innovation, mismatches in share price to market potential, or just plain great economics. (Stocks may be owned by the Sick Economist, or other commentators on this page.)

ADMA

This microcap recently acquired a manufacturing facility to ensure better quality control of its formulations for patients with immune deficiencies. After successfully addressing manufacturing issues at the new plant, ADMA is ready to refile its lead drug application with the FDA. The result should be a fully integrated R&D and manufacturing company that helps patients suffering from immune related diseases.

finviz dynamic chart for  ADMA 

SRTS

This small company patents, manufactures and sells capital equipment that dermatologists use to treat skin cancer and challenging aesthetic conditions. The company presents its radiation machines as a more appealing alternative to traditional skin surgeries.  With the number of skin cancer cases set to explode over the coming decades, Sensus Inc is only beginning to address a rapidly growing market.

finviz dynamic chart for  SRTS 

CHRS

Coherus Bioscience seeks to provide more affordable alternatives to some of the world’s most expensive biological treatments.  After many years of research and development, Coherus is slowly approaching the point of being able to offer biosimilar products; FDA approved copies of some of the most critical, and costliest, treatments in modern medicine. The market potential is vast and rapidly growing.

finviz dynamic chart for  CHRS 

BIOTECH INVESTING


Biotech investing means betting on scientific innovation. This space is dedicated to small cap biotech stocks, leading edge biotechnology research, and small stocks that have flown under the radar. Let’s talk about how you can turn innovation into profit.

ZENTALIS PHARMACEUTICALS: A BIOTECH IPO FOR BREAST CANCER

Due to Covid-19, the United States economy and the stock market has been dramatically impacted….

LISTEN UP! AKOUOS, INC IS A HOT IPO

Imagine a life without rock music, a baby’s laugh, or the sound of waves on…

INNOVATION IN THEIR BLOOD: FORMA THERAPEUTICS IPO

Biotech IPOs are currently experiencing a boom, but not in the way you would expect–although…

HEALTHCARE SERVICES


Modern healthcare equities comprise an intricate ecosystem of healthcare service providers in addition to makers of medicines and devices. Investment in insurance companies, hospitals, clinics, and many other service providers have yielded substantial profits while helping millions of people.

GENEDRIVE, PLC: WILL TESTING FOR THE MASSES EQUAL MASSIVE PROFITS?

What if you could take a test for the Cornavirus in your doctor’s office and…

ENTER THE BEAST: COULD AN INVESTOR TRIPLE HER MONEY BY INVESTING IN UNITED HEALTHCARE, INC?

Over the last ten years, United Health Inc ($UNH) has delivered a mind boggling annual…

GENESIGHT TEST FOR DEPRESSION: CRAZY PROFIT POTENTIAL FOR MYRIAD INVESTORS

Myriad Genetics, a biotech provider of molecular diagnostics for personalized medicine, has recently unveiled blockbuster…

HEALTHCARE REITs


Healthcare Real Estate (REITs) are high yielding stocks in the healthcare industry. You can invest in nursing homes, medical office buildings and research labs. Learn a profitable and easy way to invest in healthcare real estate.

HIGH YIELD HEALTHCARE: AN INTERVIEW WITH JUSSI ASKOLA

Jussi Askola is the President of Leonberg Capital, a boutique investment research firm specializing in…

3 HEALTHCARE REITS FOR STEADY RETIREMENT INCOME

With the Fed reluctant to raise interest rates further, those in or near retirement may…

3 BEST HEALTHCARE VALUE STOCKS FOR 2019

Who doesn’t love a nice Christmas sale? Everyone loves to pick up some good bargains around the holidays. When we talk about spending money, every retailer in the world advertises their big deals. But when we talk about making money, those deals may not be so obvious…

CAPITAL EQUIPMENT


Robots, radiation cannons, and molecular imaging machines aren’t just the healthcare tech of the future; they are also the source of investor profit for many decades to come. Big machines can mean big profits for equity investors.

WILL INTUITIVE SURGICAL BE PERMANENTLY CRIPPLED BY THE PANDEMIC?

Intuitive Surgical has revolutionized the minimally invasive, robotic-assisted surgical space with their FDA approved da…

LARRY CULP’S ART OF THE DEAL: 3 BUSINESS LESSONS FROM GE’S BIOPHARMACEUTICAL SALE

In a surprise move, GE has agreed to sell it’s BioPharmaceutical Division to Danaher for…

LESS PAIN, MORE GAIN: TREATING SKIN CANCER WITH SENSUS HEALTHCARE INC.

90 Day Update:  Since our original profile, Sensus Healthcare, Inc ($SRTS) has only looked better…

Subscribe To The Rx Newsletter

sick economics

You understand that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. You further understand that none of the bloggers, information providers, app providers, or their affiliates are advising you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent that any of the content published on the Site may be deemed to be investment advice or recommendations in connection with a particular security, such information is impersonal and not tailored to the investment needs of any specific person. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Site will not contain a list or description of relevant risk factors.

The Site is not intended to provide tax, legal, insurance or investment advice, and nothing on the Site should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Sick Economics or any third party. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation.

ACCEPT